Activated B12 Guard Sublingual 2000 mcg. - 100 Lozenges Perque

Perque - Activated B-12 Guard Sublingual 2000 mcg. - 100 Lozenges

Perque Activated B-12 Guard Sublingual 2000 mcg. is in lozenge form for maximum uptake and optimal delivery to the brain. Studies on Perque's Activated B-12 Guard lozenge formulation show nearly the same B-12 uptake as from injection. Patients notice that they feel better more quickly. Vitamin B-12 in our food supply is estimated to be 78% less than in the 1960s. Diet alone is hard-pressed to provide the necessary levels of this important nutrient. In addition, stress, reduced hydrochloric acid (HCl) and intrinsic factor production in the stomach impair absorption. The most commonly used forms of B-12 require activation in the body, making uptake quite low –rarely more than 50%.

Perque delivers Vitamin B-12 in its superior, activated hydroxocobalamin form. Although it is more expensive and difficult to obtain, hydroxocobalamin lasts longer and raises B-12 blood concentrations higher than other forms. For this reason, it is the only form Perque uses. Hydroxocobalamin requires no intrinsic factor and is taken up directly by mucous membranes regardless of digestive competence. Hydroxocobalamin is easily converted to active but shortlived methylcobalamin and adenosyl-cobalamin as needed in the body. Hydroxocobalamin, the parent to other B-12 forms, provides better, long-lived B-12 action in the body.

The Perque Guarantee

• Every Perque product provides 100% potency and activity for its entire shelf life.
• Every ingredient used in a Perque product is pharmaceutical-grade or better.
• All Perque products dissolve rapidly (usually within 20 minutes), eliminating digestive irritation often found with other brands.
• Full label disclosure is provided for all Perque products — no hidden ingredients.
• Every Perque product is activated with the same transporters that are used by nature and in food to ensure full bioavailability. The biologically preferred form of an ingredient is always used for enhanced activity.
• Free of citrus, MSG, wheat/gluten, corn/zein/starch, dairy/casein/whey/ milk derivatives, yeast, soy, sulfate, phosphates (other than coenzymes),and preservatives.
• No genetically modified organisms (GMOs).
• Unique post-production assays and clinical bioassays assure product integrity. 
• GMP (Good Manufacturing Practices)      

About Perque Integrative Health
The roots of Perque Integrative Health, LLC (PIH) are imbedded in the history and works of the scientist who founded the company and who has remained, with the support of a dedicated staff, at its helm for over 24 years.

Dr. Russell M. Jaffe, CEO and Chairman of PIH, worked at the National Institutes of Health (NIH) from 1973 to 1979 where the seeds of his vision began. On leaving NIH, Dr. Jaffe began a journey that sought to support the emerging field of Integrative and Regenerative Medicine. His dedication to the application of primary prevention and his commitment to providing superior nutraceuticals and autoimmune testing with clinical evidence of superior efficacy has made him a sought after speaker and leader in his chosen field. In 1984 after, five years of research, Dr. Jaffe invented a process that would eventually lead him to the family of companies he runs today. This innovation’s primary effort was to create a technology platform for measuring and monitoring all delayed allergies in the world’s first single step amplified (ELISA) procedure. When accomplished, it was the first performed in a living cell through an advanced culture technique (ACT). Today with over 50,000 cases in the lab database it remains a vibrant part of Dr. Jaffe’s integrated operations.

Expanding to Reston, then to Sterling and now to a custom built headquarters and warehouse in Ashburn, Virginia, Dr. Jaffe is continuously expanding and seeking new ways to improve his existing operations while maintaining his production lab, ELISA/ACT Biotechnologies, his Perque nutraceutical plant, and an R&D facility, RMJ Holdings Rx. Dr. Jaffe and his team of highly trained professionals continually look for new ways to help speed the transition from our current healthcare system’s symptom reactive model to a more functionally integrated, effective and compassionate system.

PIH is the turnkey outcome of years of Dr. Jaffe’s scientific research. It brings to market two decades of rethinking safer more effective, novel and proprietary dietary supplements, supplement delivery systems, diagnostic testing, and validation studies. In pilot clinical outcomes studies The Alkaline Way Program, utilizing LRA by ELISA/ACT tests for delayed hypersensitivities along with Perque supplementation to remove repair deficits, has been confirmed to achieve improvements in common conditions such as diabetes, fibromyalgia muscle pain, and chronic fatigue syndrome (CFIDS).

Today, the company creates integrated systems that implement assessment protocols and tools that combine information technology with advanced products for enhanced understanding, compliance and monitoring outcomes.

From his humble beginnings in 1984 to today, Dr. Jaffe and his team have steadily moved forward and produced a volume of evidence-based work that has profoundly enhanced functional human nutrition, integrative medicine and proactive preventive healthcare models.